Catherine Sohn

Catherine Sohn

DirectoratAltimmune· In proxies 2023–2025

Catherine Sohn sits on 9 public boards.

Experience

  1. AltimmunePublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -86%
  2. Jazz PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Maze TherapeuticsPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  4. BB Biotech AG Y-mAbs Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Acceleron Pharma Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. AnaptysBio, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. Pardes Biosciences, Inc.Public company
    • Director? – PresentNo stock prices for these years
  8. Scilex Holding CompanyPublic company
    • Director? – PresentNo stock prices for these years
  9. Axcella HealthPublic company · 4 yr
    • Director2019 – 2023 · 4 yrNo stock prices for these years
  10. Rubius TherapeuticsPublic company · 5 yr
    • Director2018 – 2023 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?